Literature DB >> 27209011

In Vitro Susceptibility of Pythium insidiosum to Melaleuca alternifolia, Mentha piperita and Origanum vulgare Essential Oils Combinations.

Júlia de Souza Silveira Valente1, Anelise de Oliveira da Silva Fonseca1, Laura Bedin Denardi2, Vanessa Silveira Dal Ben1, Fernando de Souza Maia Filho1, Cristiane Telles Baptista1, Caroline Quintana Braga1, Cristina Gomes Zambrano1, Sydney Hartz Alves2, Sônia de Avila Botton2, Daniela Isabel Brayer Pereira3.   

Abstract

Pythium insidiosum is the etiologic agent of pythiosis, a severe and emerging disease that affects mammals. Failure of conventional antifungal therapies is partially justified by the absence of ergosterol in the plasma membrane of this oomycete. Despite research advancement, the treatment of pythiosis has not been not fully established. The present study investigated the in vitro susceptibility profile of Brazilian isolates of P. insidiosum (n = 20) against Melaleuca alternifolia, Mentha piperita and Origanum vulgare essential oils, and their combinations. Susceptibility tests were performed according to CLSI M38-A2 protocol, and combinations were evaluated by the microdilution cherkerboard method. All tested essential oils showed antimicrobial activity against P. insidiosum, and the greatest activity of O. vulgare was highlighted. Synergistic and/or indifferent effect was observed for all combinations evaluated, especially the M. piperita and O. vulgare combination, which showed 65 % synergism. This is the first study to report in vitro combinations of essential oils against P. insidiosum indicating the susceptibility of this oomycete to M. alternifolia, M. piperita and O. vulgare essential oils, as well as their combinations.

Entities:  

Keywords:  Mint; Oomycete; Oregano; Pythiosis; Sinergism; Tea tree

Mesh:

Substances:

Year:  2016        PMID: 27209011     DOI: 10.1007/s11046-016-0019-2

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  28 in total

1.  Coumarinoids from the fruits of Micromelum falcatum.

Authors:  Jittra Suthiwong; Uraiwan Sriphana; Yordhathai Thongsri; Pawantree Promsuwan; Chularut Prariyachatigul; Chavi Yenjai
Journal:  Fitoterapia       Date:  2014-02-19       Impact factor: 2.882

2.  In vitro activity of carvacrol and thymol combined with antifungals or antibacterials against Pythium insidiosum.

Authors:  F P K Jesus; L Ferreiro; K S Bizzi; É S Loreto; M B Pilotto; A Ludwig; S H Alves; R A Zanette; J M Santurio
Journal:  J Mycol Med       Date:  2014-11-13       Impact factor: 2.391

3.  Synergy assessed by checkerboard. A critical analysis.

Authors:  M H Hsieh; C M Yu; V L Yu; J W Chow
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

4.  Micafungin alone and in combination therapy with deferasirox against Pythium insidiosum.

Authors:  R A Zanette; F P K Jesus; M B Pilotto; C Weiblen; L Pötter; L Ferreiro; S H Alves; J M Santurio
Journal:  J Mycol Med       Date:  2014-11-20       Impact factor: 2.391

Review 5.  Pythium insidiosum: an overview.

Authors:  Wim Gaastra; Len J A Lipman; Arthur W A M De Cock; Tim K Exel; Raymond B G Pegge; Josje Scheurwater; Raquel Vilela; Leonel Mendoza
Journal:  Vet Microbiol       Date:  2010-07-24       Impact factor: 3.293

6.  In vitro susceptibility of zoospores and hyphae of Pythium insidiosum to antifungals.

Authors:  A O S Fonseca; D I B Pereira; F S Maia Filho; L G Osório; B P Maroneze; J S S Valente; L Pötter; M C A Meireles
Journal:  J Antimicrob Chemother       Date:  2014-02-11       Impact factor: 5.790

7.  Trypanocidal action of tea tree oil (Melaleuca alternifolia) against Trypanosoma evansi in vitro and in vivo used mice as experimental model.

Authors:  Matheus D Baldissera; Aleksandro S Da Silva; Camila B Oliveira; Roberto C V Santos; Rodrigo A Vaucher; Renata P Raffin; Patrícia Gomes; Maria G C Dambros; Luiz C Miletti; Aline A Boligon; Margareth L Athayde; Silvia G Monteiro
Journal:  Exp Parasitol       Date:  2014-03-19       Impact factor: 2.011

8.  Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals.

Authors:  Daniela Isabel Brayer Pereira; Janio Morais Santurio; Sydney Hartz Alves; Juliana Siqueira Argenta; Luciana Pötter; Andréia Spanamberg; Laerte Ferreiro
Journal:  J Antimicrob Chemother       Date:  2007-09-03       Impact factor: 5.790

9.  Antimicrobial screening of Mentha piperita essential oils.

Authors:  Gökalp Işcan; Neşe Kirimer; Mine Kürkcüoğlu; K Hüsnü Can Başer; Fatih Demirci
Journal:  J Agric Food Chem       Date:  2002-07-03       Impact factor: 5.279

10.  Pythiosis in Africa.

Authors:  Christine Rivierre; Caroline Laprie; Olivier Guiard-Marigny; Patrick Bergeaud; Madeleine Berthelemy; Jacques Guillot
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

View more
  3 in total

1.  Melaleuca alternifolia formulations in the treatment of experimental pythiosis.

Authors:  Júlia de Souza Silveira; Carolina Litchina Brasil; Caroline Quintana Braga; Ândrios da Silva Moreira; Helen Cabaldi Franz; Rosimeri Zamboni; Eliza Simone Sallis; Ana Paula Albano; Cristina Gomes Zambrano; Lara Colles Araujo; Cristiane de Bona da Silva; Luciana Pötter; Sônia de Avila Botton; Daniela Isabel Brayer Pereira
Journal:  Braz J Microbiol       Date:  2022-03-03       Impact factor: 2.214

2.  In Vitro Activity of Melaleuca alternifolia (Tea Tree) in Its Free Oil and Nanoemulsion Formulations Against Pythium insidiosum.

Authors:  Júlia de Souza Silveira Valente; Anelise de Oliveira da Silva Fonseca; Carolina Litchina Brasil; Lauren Sagave; Fernanda Cramer Flores; Cristiane de Bona da Silva; Luís Antônio Sangioni; Luciana Pötter; Janio Morais Santurio; Sônia de Avila Botton; Daniela Isabel Brayer Pereira
Journal:  Mycopathologia       Date:  2016-08-20       Impact factor: 2.574

Review 3.  Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum.

Authors:  Hanna Yolanda; Theerapong Krajaejun
Journal:  Heliyon       Date:  2020-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.